LB Pharmaceuticals Inc (LBRX) Stock
LB Pharmaceuticals stock price chart
LBRX stock quote & key statistics
LB Pharmaceuticals annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$25.2M | -$2.50 |
| FY2024 | $0 | -$63.1M | — |
| FY2023 | $0 | -$6.3M | — |
| FY2022 | $0 | -$14.3M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About LB Pharmaceuticals Inc
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
LB Pharmaceuticals stock FAQ
What is the LB Pharmaceuticals stock ticker symbol?
LB Pharmaceuticals Inc trades on the NASDAQ under the ticker symbol LBRX.
What sector and industry is LB Pharmaceuticals in?
LB Pharmaceuticals Inc is classified in the Healthcare sector, Biotechnology industry.
How many employees does LB Pharmaceuticals have?
LB Pharmaceuticals Inc has about 49 full-time employees.
What were LB Pharmaceuticals's revenue and earnings last fiscal year?
LB Pharmaceuticals reported revenue of $0 and net income of -$25.2M in fiscal 2025, with earnings per share of -$2.50.
Is LB Pharmaceuticals in the Russell 2000?
Yes. LB Pharmaceuticals Inc (LBRX) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did LB Pharmaceuticals go public?
LB Pharmaceuticals stock began trading on September 11, 2025.
Russell 2000 Biotechnology stocks
All Russell 2000 →- CGONCG Oncology
- COGTCogent Biosciences
- CRSPCRISPR Therapeutics
- CYTKCytokinetics
- DFTXDefinium Therapeutics
- DNTHDianthus Therapeutics
- IBRXImmunityBio
- IOVAIovance Biotherapeutics
- KODKodiak Sciences
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- MIRMMirum Pharmaceuticals
- ORKAOruka Therapeutics
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SRRKScholar Rock
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TVTXTravere Therapeutics
- TWSTTwist Bioscience